India, July 3 -- Nethradhama Superspeciality Eye Hospital, Mysuru, has launched the city's first dedicated Centre of Excellence (CoE) for Minimally Invasive Glaucoma Surgery (MIGS), offering new hope to people affected by one of India's leading causes of irreversible blindness. Glaucoma affects nearly 11.9 million people across the country and is responsible for more than 12 percent of all blindness.

"The newly introduced MIGS treatment at Nethradhama offers a modern, patient-friendly solution for those living with mild to moderate glaucoma," saidDr Monica Anand, Senior Consultant, Phaco and Glaucoma, Nethradhama Mysuru.

In addition to the iStent inject-W, the centre also offers excisional goniotomy using the Kahook Dual Blade. In this ...